Subscribe | xLM's ContinuousTV Weekly Newsletter

This website uses cookies

Read our Privacy policy and Terms of use for more information.

xLM's ContinuousTV Weekly Newsletter

Join the list to receive our newest posts straight to your inbox.

100% free, unsubscribe anytime.

Latest

#0111: From Compliance Function to Strategic Influence - Key Insights from xLM Live with Mike Magee

LinkedIn Live

#0111: From Compliance Function to Strategic Influence - Key Insights from xLM Live with Mike Magee

Nagesh Nama, +1

•

Jun 3, 2026

#0110: Why GxP Manufacturing Cannot Afford to Lag Behind in the Age of AI Agents

#0110: Why GxP Manufacturing Cannot Afford to Lag Behind in the Age of AI Agents

Nagesh Nama, +2

•

May 28, 2026

#109: The Board’s View of Quality Risk: Governance, AI, and the New cGMP Playbook

#109: The Board’s View of Quality Risk: Governance, AI, and the New cGMP Playbook

Nagesh Nama, +1

•

May 21, 2026

#0108: AI-Driven Drug Discovery and Autonomous GxP Operations: How ContinuousOS Is Reshaping the Future of Pharma

#0108: AI-Driven Drug Discovery and Autonomous GxP Operations: How ContinuousOS Is Reshaping the Future of Pharma

Nagesh Nama, +1

•

May 13, 2026

#107: FDA's Real-Time Clinical Trial Revolution: A Wake-Up Call for the Life Sciences Industry

FDA

+1

#107: FDA's Real-Time Clinical Trial Revolution: A Wake-Up Call for the Life Sciences Industry

Nagesh Nama, +1

•

May 6, 2026

#0106: From Vision to Reality: AI, Compliance, and the Reinvention of Pharma Manufacturing

FDA Special Programs

+2

#0106: From Vision to Reality: AI, Compliance, and the Reinvention of Pharma Manufacturing

Nagesh Nama, +1

•

Apr 29, 2026